CollPlant Biotechnologies (CLGN) Change in Inventory (2018 - 2026)
CollPlant Biotechnologies (CLGN) reported Change in Inventory of -$103000.0 for Q1 2026, up 55.41% on a YoY basis from -$66275.8 in Q1 2025, and down 221.88% quarter-over-quarter from -$32000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Change in Inventory (2018 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Change in Inventory for 9 years, with the latest figure at -$103000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 55.41% year-over-year to -$103000.0; the trailing twelve-month figure through Mar 2026 stood at -$1000.0 (up 95.65% YoY), and the FY2025 full-year result was -$129000.0, down 146.07% from the prior year.
- Change in Inventory for Q1 2026 stood at -$103000.0, down from -$32000.0 in the prior quarter.
- The five-year high for Change in Inventory was $856000.0 in Q4 2023, with the low at -$345000.0 in Q1 2023.
- Historically, Change in Inventory has averaged $25764.7 across 5 years, with a median of $14000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Inventory sank 1330.77% — and 2023, when it jumped 374.36%.
- CollPlant Biotechnologies' Change in Inventory stood at -$312000.0 in 2022, then jumped by 374.36% to $856000.0 in 2023, then tumbled by 98.25% to $15000.0 in 2024, then slumped by 313.33% to -$32000.0 in 2025, then plunged by 221.88% to -$103000.0 in 2026.
- The last three Change in Inventory figures came in at -$103000.0 (Q1 2026), -$32000.0 (Q4 2025), and $14000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | -103,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -103,000.00 |
| Mar 31, 2026 | -103,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | -231,000.00 |
| Mar 31, 2025 | -231,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 856,000.00 |
| Dec 31, 2023 | 856,000.00 |